Standardised incidence ratios (SIRs) and standardised mortality ratios (SMRs) for major cancer types, with 95% confidence intervals (95% CI); males
| Cancer site (ICD-9) | Obs/Exp cancers | SIR | 95% CI | Obs/Exp deaths | SMR | 95% CI |
|---|---|---|---|---|---|---|
| *Not a registrable disease in most Australian cancer registries. | ||||||
| †Expected value could not be computed due to grouping of ICD-9 190 in national data into ICD 190–199. | ||||||
| Lip, oral cavity, pharynx (140–149) | 39/52.9 | 0.74 | 0.52 to 1.00 | 6/13.0 | 0.46 | 0.17 to 1.00 |
| Oesophagus (150) | 6/11.8 | 0.51 | 0.19 to 1.11 | 6/11.0 | 0.54 | 0.20 to 1.18 |
| Stomach (151) | 26/24.5 | 1.06 | 0.69 to 1.56 | 15/14.6 | 1.03 | 0.58 to 1.70 |
| Colon (153) | 64/68.5 | 0.93 | 0.72 to 1.19 | 27/32.4 | 0.83 | 0.55 to 1.21 |
| Rectum (154) | 49/47.9 | 1.02 | 0.76 to 1.35 | 11/13.3 | 0.83 | 0.41 to 1.48 |
| Liver (155) | 6/7.1 | 0.84 | 0.31 to 1.84 | 4/6.9 | 0.58 | 0.16 to 1.49 |
| Gall bladder (156) | 4/4.4 | 0.92 | 0.25 to 2.35 | 3/2.1 | 1.41 | 0.29 to 4.12 |
| Pancreas (157) | 16/15.2 | 1.05 | 0.60 to 1.71 | 10/14.6 | 0.69 | 0.33 to 1.26 |
| Larynx (161) | 14/15.2 | 0.92 | 0.50 to 1.55 | 2/5.3 | 0.38 | 0.05 to 1.36 |
| Lung (162) | 73/111.9 | 0.65 | 0.51 to 0.82 | 62/93.6 | 0.66 | 0.51 to 0.85 |
| Pleura (163) | 11/6.1 | 1.80 | 0.90 to 3.22 | 6/3.1 | 1.96 | 0.72 to 4.27 |
| Connective tissue (171) | 6/7.4 | 0.81 | 0.30 to 1.76 | 2/2.2 | 0.93 | 0.11 to 3.35 |
| Melanoma (172) | 143/92.9 | 1.54 | 1.30 to 1.81 | 11/13.4 | 0.82 | 0.41 to 1.47 |
| Non-melanotic skin (173) | * | 2/3.5 | 0.56 | 0.07 to 2.04 | ||
| Prostate (185) | 137/115.3 | 1.19 | 1.00 to 1.40 | 18/18.4 | 0.98 | 0.58 to 1.55 |
| Testis (186) | 14/11.3 | 1.24 | 0.68 to 2.08 | 1/0.82 | 1.22 | 0.03 to 6.8 |
| Bladder (188) | 46/33.5 | 1.37 | 1.00 to 1.83 | 6/6.1 | 0.98 | 0.36 to 2.13 |
| Kidney (189) | 28/24.5 | 1.14 | 0.76 to 1.65 | 13/8.8 | 1.49 | 0.79 to 2.54 |
| Eye (190) | 5/2.7 | 1.85 | 0.60 to 4.31 | † | ||
| Brain/nervous system (191–192) | 16/17.0 | 0.94 | 0.54 to 1.53 | 15/14.2 | 1.06 | 0.59 to 1.74 |
| Non-Hodgkin’s lymphoma (200–202) | 32/33.6 | 0.95 | 0.65 to 1.35 | 11/13.4 | 0.82 | 0.40 to 1.47 |
| Multiple myeloma (203) | 15/8.7 | 1.72 | 0.96 to 2.84 | 8/4.9 | 1.63 | 0.70 to 3.22 |
| All leukaemias (204–208) | 27/19.5 | 1.39 | 0.91 to 2.02 | 16/10.9 | 1.47 | 0.84 to 2.39 |
| Acute lymphatic leukaemia (204.0) | 1/1.2 | 0.84 | 0.02 to 4.68 | 2/1.1 | 1.81 | 0.22 to 6.56 |
| Chronic lymphatic leukaemia (204.1) | 7/7.2 | 0.97 | 0.39 to 2.00 | 0/1.8 | 0 | |
| Acute myeloid leukaemia (205.0) | 6/5.8 | 1.04 | 0.38 to 2.27 | 5/4.90 | 1.03 | 0.33 to 2.39 |
| Chronic myeloid leukaemia (205.1) | 4/3.4 | 1.18 | 0.32 to 3.02 | 4/2.0 | 2.03 | 0.55 to 5.20 |
| All other leukaemias | 9/1.9 | 4.65 | 2.13 to 8.83 | 5/1.2 | 4.33 | 1.40 to 10.1 |
| Other and unspecified sites | 36/50.9 | 0.70 | 0.50 to 0.98 | 25/27.8 | 0.90 | 0.58 to 1.33 |
| All malignant (excluding 173) | 813/782.7 | 1.04 | 0.97 to 1.11 | 280/334.2 | 0.84 | 0.74 to 0.94 |